Bioventus Inc. (BVS) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $179.93M | -2.8% |
| 2024 | $185.05M | +0.5% |
| 2023 | $184.15M | +1.7% |
| 2022 | $181.04M | +41.2% |
| 2021 | $128.19M | +46.3% |
| 2020 | $87.64M | -3.6% |
| 2019 | $90.94M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $179.93M | -2.8% |
| 2024 | $185.05M | +0.5% |
| 2023 | $184.15M | +1.7% |
| 2022 | $181.04M | +41.2% |
| 2021 | $128.19M | +46.3% |
| 2020 | $87.64M | -3.6% |
| 2019 | $90.94M | — |